Eli Lilly to acquire Scorpion for up to $2.5B - MSN

Eli Lilly (NYSE:LLY) has agreed to buy Scorpion Therapeutics' lead drug program for up to $2.5B in cash and spin out the remaining company as a new entity focused on precision medicine. …


$2
OFF

Eli Lilly To Acquire Scorpion For Up To $2.5B - MSN

2 weeks from now

Eli Lilly (NYSE:LLY) has agreed to buy Scorpion Therapeutics' lead drug program for up to $2.5B in cash and spin out the remaining company as a new entity focused on precision medicine. …

msn.com

$2
OFF

Eli Lilly To Acquire Scorpion Therapeutics' Breast Cancer ... - MSN

2 weeks from now

Eli Lilly (LLY) agreed to acquire an experimental treatment for breast cancer and other advanced solid tumors from Scorpion Therapeutics for up to $2.5 billion. The purchase price includes an ...

msn.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics Drug Program In $2.5 ... - MSN

2 weeks from now

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 …

msn.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics Drug Program In $2.5 Billion ...

2 weeks from now

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 …

wsj.com

$2
OFF

Eli Lilly In Advanced Talks To Buy US Cancer Biotech For Up To $2.5bn

2 weeks from now

4 days ago  · Eli Lilly, the world’s largest drugmaker by market value, is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5bn, according to …

ft.com

$2
OFF

Eli Lilly To Acquire Cancer Program From Scorpion Therapeutics

2 weeks from now

1 day ago  · SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company …

statnews.com

$2
OFF

Lilly To Pay As Much As $2.5 Billion For Scorpion’s Cancer Drug

2 weeks from now

1 day ago  · Eli Lilly & Co. will pay as much as $2.5 billion in cash to acquire a cancer drug that Scorpion Therapeutics Inc. is testing in early and mid-stage trials.

bloomberg.com

$2
OFF

Eli Lilly To Acquire Scorpion Therapeutics' Mutant PI3Kα Inhibitor …

2 weeks from now

23 hours ago  · NEW YORK – Eli Lilly on Monday said it will acquire Scorpion Therapeutics' mutant-PI3Kα inhibitor STX-478 for up to $2.5 billion while Scorpion spins out a new entity to …

precisionmedicineonline.com

$2
OFF

Eli Lilly To Acquire Scorpion Therapeutics’ Cancer Program For Up …

2 weeks from now

Pharmaceutical company Eli Lilly has entered into a definitive agreement to acquire Scorpion Therapeutics’ cancer therapy program for up to $2.5 billion as part of its efforts to strengthen …

forbesmiddleeast.com

$2
OFF

Lilly In Advanced Talks To Buy Cancer Biotech Scorpion For Up To …

2 weeks from now

4 days ago  · Eli Lilly is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks told Financial Times’ Oliver Barnes, Maria …

businessinsider.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics' Cancer Therapy For Up To

2 weeks from now

(Reuters) -Eli Lilly said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of cancer treatments. The company …

msn.com

$2
OFF

Lilly Circles $2.5B Scorpion Buy As Pre-JPM Rumour Mill Churns

2 weeks from now

4 days ago  · Eli Lilly is said to be in advanced discussions to acquire cancer-focused biotech Scorpion Therapeutics for up to $2.5 billion, marking the second major potential acquisition …

firstwordpharma.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics' Cancer Therapy For Up To $2.5 ...

2 weeks from now

1 day ago  · Eli Lilly said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of cancer treatments.

reuters.com

$2
OFF

Lilly Nets Scorpion Cancer Drug In $2.5bn Licensing Deal

2 weeks from now

1 day ago  · Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of …

pharmaphorum.com

$2
OFF

Eli Lilly And Company Entered Into An Agreement To Acquire …

2 weeks from now

1 day ago  · Eli Lilly and Company (NYSE:LLY) entered into an agreement to acquire Scorpion Therapeutics, Inc. for $2.5 billion on January 13, 2025. Under the terms of the agreement, Lilly …

marketscreener.com

$2
OFF

Eli Lilly To Acquire Cancer-Focused Biotech Scorpion Therapeutics …

2 weeks from now

4 days ago  · Eli Lilly, the world’s largest drugmaker by market value, is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5bn. Eli Lilly’s pursuit …

healthcarepress.net

$2
OFF

Eli Lilly To Buy Cancer Drug Developer Scorpion Therapeutics For

2 weeks from now

(Reuters) -Eli Lilly said on Monday it would buy cancer therapy developer Scorpion Therapeutics for up to $2.5 billion in cash. Lilly will acquire Scorpion's experimental oral therapy, STX-478 ...

msn.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics Drug Program In $2.5 Billion ...

2 weeks from now

1 day ago  · Eli Lilly has agreed to acquire Scorpion Therapeutics' breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and …

marketscreener.com

$2
OFF

Eli Lilly In Talks To Acquire Scorpion Therapeutics, FT Says ... - MSN

2 weeks from now

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. Eli Lilly (NYSE:LLY) is expected to pay around $1 …

msn.com

$2
OFF

Eli Lilly In Talks To Acquire Scorpion Therapeutics... | DeepNewz

2 weeks from now

4 days ago  · Eli Lilly, the world's largest drugmaker by market value, is in advanced negotiations to acquire Scorpion Therapeutics, a U.S.-based cancer biotech firm, for up to $2.5 billion, …

deepnewz.com

$2
OFF

Eli-lilly-said-to-be-in-talks-to-buy-scorpion-therapeutics-for-2-5b ...

2 weeks from now

Eli Lilly and Company is in advanced talks to acquire biotechnology company Scorpion Therapeutics for $2.5 billion, the Financial Times reported on Friday, citing people briefed on …

baha.net

$14
OFF

JNJ, GSK, LLY Announce M&A Deals At JP Morgan Conference - MSN

2 weeks from now

While J&J announced a big deal to acquire neuroscience company Intra-Cellular Therapies ITCI, Lilly and GSK announced smaller deals.. J&J Offers to Buy ITCI for $14B. The drug and …

msn.com

FAQs about Eli Lilly to acquire Scorpion for up to $2.5B - MSN Coupon?

Does Eli Lilly own Scorpion Therapeutics?

As part of the deal, Lilly will hold a minority stake in a new entity that Scorpion will spin out. Photo: Scott Olson/Getty Images Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. ...

How much will Eli Lilly pay for Scorpion?

Eli Lilly (NYSE: LLY) is expected to pay around $1 billion upfront for the privately owned Scorpion, according to a Financial Times report on Friday, which cited people familiar with the matter. Lilly will pay as much as an additional $1.5 billion at a later day if the biotech hits certain milestones. ...

How much will Lilly pay Scorpion shareholders?

Scorpion's lead drug asset, a mutant-selective PI3Kα inhibitor known as STX-478, is currently in Phase 1/2 testing for the treatment of breast cancer and other solid tumors. Under the deal, Lilly will pay Scorpion shareholders up to $2.5B in cash, including an upfront payment and potential milestone payments. ...

Who owns Scorpion & Lilly?

As part of the deal, Scorpion will spin out a new entity to hold its employees and other pipeline assets that aren’t related to the breast cancer treatment program. The new company will be owned by Scorpion’s current shareholders, while Lilly will hold a minority stake. A timeline for the transaction wasn’t disclosed. ...

How did Eli Lilly perform in the third quarter?

For the third quarter, the pharma giant reported 17% sales growth in its non-incretin division, which includes its oncology, immunology and neuroscience portfolios. Eli Lilly (LLY) agreed to acquire an experimental treatment for breast cancer and other advanced solid tumors from Scorpion Therapeutics for up to $2.5 billion. ...

Will Scorpion buy stx-478?

The company will acquire Scorpion's experimental oral therapy, STX-478, which is currently being tested in early-stage trials for breast cancer and other advanced solid tumors. The therapy is a PI3K inhibitor, which selectively targets a type of protein called PI3K. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension